Cochlear Limited (OTCMKTS:CHEOF – Get Free Report) shares crossed above its two hundred day moving average during trading on Tuesday. The stock has a two hundred day moving average of $104.39 and traded as high as $105.41. Cochlear shares last traded at $105.41, with a volume of 20 shares traded.
Cochlear Price Performance
The stock has a 50-day moving average of $94.81 and a 200 day moving average of $104.39.
Cochlear Company Profile
Cochlear Limited is an Australian medical device company that develops, manufactures and supplies implantable hearing solutions. Its products are designed for people with severe to profound hearing loss who may not receive sufficient benefit from conventional hearing aids. The company’s portfolio includes cochlear implants, bone-conduction hearing implants and related sound processors, accessories and connectivity products. Cochlear also provides clinical support, rehabilitation resources and ongoing services for recipients, hearing professionals and healthcare providers.
Further Reading
- Five stocks we like better than Cochlear
- Why Kinder Morgan’s Chairman Just Bought $15 Million in Stock
- Rocket Lab’s Record Backlog Could Fuel a Rebound, But Neutron Raises the Stakes
- Don’t Let Their Low Yields Fool You: 3 Dividend Stocks Worth Watching
- A $4 Billion Jolt: NRG Energy Powers Data Center Ambitions
Receive News & Ratings for Cochlear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cochlear and related companies with MarketBeat.com's FREE daily email newsletter.
